New Head For SymCel To Push Commercial Phase
SymCel Sverige AB has appointed a new CEO with strong commercial experience to succeed Christer Wallin, who is now retiring.
You may also be interested in...
Swedish firm Symcel has set its sights on the medical diagnostics field, in particular the area of antibiotic drug resistance, as part of a strategy to expand its calScreener calorimetric technology for cell-based assay beyond the current drug discovery and academic research applications.
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.